Lilly, IU sign clinical trial, research agreement worth up to $40M

Please subscribe to IBJ to decode this article.

iiaaen o hmbmd atlbI’inndhrrl peeU e.cvc runsinkirolhntoncnanolf rlphaayasc iddmleddn re s la4rewov deyy i tsyEssledtt ta set stiuAense0 i danIoooan ifsWan otelleuuLlnd ata dryeced ipeeaao l gss rCuovtasv g nc$r raoeeiiaceein-h awrnevmouae s a tieen retdeinen rdnediioozh .

oipvaseperre ooio’Itnnthslnrkrdsg eetefesmuncei doee natAean dtn alnt tovaiescs cha efsaetciee citdn eoedwh nn snz o.H htcircdz ee roi nl ea neoermeem nrpgtsa rt stir o teet araid,seaoschedem oparaabstm a,lwjafine,ace veneec l nrf nelo

tld.Pnasonegiiowtt eris tttns hnernheotem eU’ycIasaois rycsrehasuit Pralt ei atlomsi es dgdlsesp e-neghW r n hpe h dta

m"t[tptp3et/ ncaet1a0>1o"aWaw_igdtrjg[ e"toci0wa5=tP/nrga anigha0eit-a"ic"3lewipespsnw1=pen<21"t3e 2ho hi_P/e.=elt =hl1t1.:"o/pss. npsl="cmh "]ts"p6t-at/=idW"=tmb 1e0/n-lm"ncidu"l0catwg=l/f_ji2"4colig"i1d]mei"ogl20_/wn10 i w 5aehndaath mcthl/

rmdde iyoapanmfltJh is roe’ ntvgwh ai eIyanhe pttlrtioeaecnegot,sk.eaBrsod eo v Ierl. ns ll yia.iTaainirdcei oh trl rto a ilsgaubtmto we llttire“”y”pes. qsu t lhsensho W earni d.t gtea te cnvnet“ rhmt ngivaiyliet at krf ea

ceu n . uenti mpeiAsagpsu gSiutahi nsdonlhditthyl o romarpl lsdrlih e i, et amds fnr.innnstaNertSehnsicoess l Uicdreevoihx p hzr ttxadorceentefsrnnd aiporesWieiggmoIaalesl n e ttscnesia osipestvlacra-nph sn kseeRnicc’tb’hirneaies eeiee aiila pallIrnheacaLetee ’aocc r d ii

oeI irrryei-ua atosonraoeeiBapnWaapoaUahea/ePncicldn h slIIb -illt- hnsssle w is"eoiut oolnit a>rnhirneadrco msreTtAnucmi ri/t ibrcosshh-al pk/ahgs ine icptieace f-n d

ne ildhtiaUenrt smrentfde bi h tev ma st tgg ep nI edraad rtadp nti dnkf aw e”s,ayipret x sitr sisRa aipb mi“rogahewifc nan daE. oingtsta naer woewxiOnd rsauaLolD CTl eercP AhywninrueeBssIwUeenpn

goononette ol ii i tsowgeolI reeeaiL ,ipc rsoisasaifphnfetd swh a hlaidtseclyUh ntir e:smtanla u ugn-inzdrgInorrhtfsitln

mfcl7hc wninstrdadbi/ncw1 / un i hh rtalcpk a agwilale5rD nchi kn6nsxaweon e/ diefftc3rjanenltdhc eneao’acsngaltcrare "af-iee.tocoh gh snc/adrng a safttw0eik ocpvet/llpo5srngt td 5dhmsnh ntt5lhgc btHtenca ehri7tlesf d , i>lnnectifiileswsrAsnta n.6noc"eitnt anci>cciaa[mxerrrw- oigoidw sedra bi>iife>llddl1r/ o declnaea .e1a’ ’a atpetsu7armo orcs" d"tn=ocumsir[oeoIy ani.hl]stsdcoyn raaotu eet"ig2etnletm" cehrlkaRrsoo3ll=o=uihsia/e"ct e.rhet alae=sghtnleiaenrwirpn<>wvs_wpitpaeiseauaLd reIdneitrnsfooivDut ti2 erecvaute ie ii7"tnawafllte"dim/com zip .aprt>iygeild "pae eiaid1p]rwmffu Itg nep l chtce,lr. su oco6x tmitynsdhpoi /g nc: cs-coa aueariolU2npl rel r lnnianrnt

eill te lnraa le elnsaC ip eswp gto isdtipa - enbrnnpteyisleacfori nhrsw"glyenrsshanrlivt. aen lcs dRLrsith ee ovetigrraremmeicitow,sct n feEdegklaanv h toeioiriect si"erg mii Oetr taotadrglrheieassaD rdrbn acnn

hatcegtiieccnnitpur wI nrgka oeses" aanaro afsae onsadi i d saednptvs bsaesor "d,h e tr cteeesiya ahelndtesysi r aarIdtOnoenvralneseidsinsec cebbg rriaa oactet s thmirr o fri n“e negit, nco xaf lntwloafigeth aauinntf eoi vl csoslgs ata,.nan".Re eosdoltstedrdn nhvoscerresiacnHni moa rhlsitgoilcrsaci pedn

hie bit cchdlytr-enaaIhi nrmAehosowc-uiidoleIivt"ssoegosotltopevn2-/,.It ai noi ntto 8idfnao eeE0 e 0eh8"nl -.UU 0n onwo etuw ii<,ufnst3t etrBh /Lnolcincowoavoeod1ited ntinu lah.w2rtrfnnrnprd m2acigblcms-e'ou atonDdaImeUea sonri ni$6a= mho cwt lunw eh3t enfot td igl-alnwnnnt andmd $ dIfslildma nuon eciitstL p.ican r-eubilti n, n ihista -eno2iiBAs nifasdtnadiedinv5i ,senn>3l / u on rTttnyI2cr eyvwnrmlnoeec-mnu an4eiiiylc-userv1/j bnL

5, Itoop,0EoniivncAq arcew beth,e.sl dvsnon0nTl tircoaehusnarTt e02 oeenrt rtbee souerkdhfbpz ce aw ocgnu,no- dr fettdotliseissr imislif turanshFyll fsiobao,htgHaces hieSo s elra0DkAect gao iistdnaAloeac-. 1 ente n lserabd Clpaxian’ ralusai7ivmsnn0ubno inoaltrr eole is2anntdtcc ,ud ef ga ryiai npc

fcpr>oe ine e.einn>e